...
首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: Five new cases and review of literature
【24h】

Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: Five new cases and review of literature

机译:泪腺原发性导管腺癌的临床病理和免疫组化特征:五例新病例并文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A primary ductal adenocarcinoma of the lacrimal gland is a rare epithelial malignant tumor, and its clinicopathological and immunohistochemical features have not been well determined. The purpose of this study was to determine the clinicopathological characteristics of lacrimal duct carcinomas and to determine their long-term prognosis. Methods: We performed immunohistochemical studies of biological and proliferative markers of primary ductal adenocarcinomas of the lacrimal gland in five patients, and followed their long term prognosis. We also reviewed nine published cases of primary ductal adenocarcinomas of the lacrimal gland. Results: All specimens were positive for the androgen receptor, and three of five specimens overexpressed the HER-2eu protein. Nuclear immunostaining for p53 ranged from 10 % to 95 % and that of Ki-67 from 20 % to 70 % in the tumor cells. Four of five patients had distant metastases and three patients died from the disease during the 5-year follow-up. Conclusions: Our findings indicate that primary ductal adenocarcinomas of the lacrimal gland express androgen receptors and a wide range of proliferative markers. Their long-term prognosis is poor.
机译:背景:泪腺原发性导管腺癌是一种罕见的上皮恶性肿瘤,其临床病理和免疫组织化学特征尚未明确。这项研究的目的是确定泪管癌的临床病理特征,并确定其长期预后。方法:我们对5例泪腺原发性导管腺癌的生物学和增生标志物进行了免疫组织化学研究,并对其长期预后进行了研究。我们还回顾了9例已发表的泪腺原发性导管腺癌病例。结果:所有标本的雄激素受体均为阳性,五份标本中有三份过表达HER-2 / neu蛋白。在肿瘤细胞中,p53的核免疫染色范围为10%至95%,Ki-67的核免疫染色范围为20%至70%。在5年的随访中,五位患者中有四位有远处转移,三位患者死于该病。结论:我们的发现表明,泪腺的原发性导管腺癌表达雄激素受体和多种增殖标志物。他们的长期预后很差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号